Latest DrugPricing News and Updates : DrugPricing updates, DrugPricing News , DrugPricing around the world

Nishadil

Washington | 24°C (moderate rain)

Trump’s Secret Pharma Deals Threaten ‘Most‑Favored Nation’ Savings

Top story

Trump’s Secret Pharma Deals Threaten ‘Most‑Favored Nation’ Savings

In focus

Latest feed

Trump’s Quiet Pharma Deals Threaten Big Medicare Savings

Barriers May Keep Merck’s New Cholesterol Pill From Success

Merck’s First Oral PCSK9 Inhibitor Faces Real‑World Hurdles

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

Latest headlines

Iowa Medicaid Audit Exposes $100 Million PBM Overcharges and Creative Spread‑Pricing Workarounds

Iowa Medicaid Audit Exposes $100 Million PBM Overcharges and Creative Spread‑Pricing Workarounds

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

Europe's Most Favored Nation Drug Pricing Push: A Looming Challenge for Innovation and Access

Europe's Most Favored Nation Drug Pricing Push: A Looming Challenge for Innovation and Access

The Unveiling: Trump's Most Favored Nation Drug Pricing Secrets Are About To Surface

The Unveiling: Trump's Most Favored Nation Drug Pricing Secrets Are About To Surface

The Humira Enigma: How a Patent Fortress Redefined Pharma Monopolies

The Humira Enigma: How a Patent Fortress Redefined Pharma Monopolies

The Unseen Hand: How Pharma Giants Shape Policy Through Academic Influence

The Unseen Hand: How Pharma Giants Shape Policy Through Academic Influence

The Quiet Influence: Pharma's Play in Shaping Policy

The Quiet Influence: Pharma's Play in Shaping Policy

The Generic Drug Wars: TrumpRx Enters a Crowded Arena

The Generic Drug Wars: TrumpRx Enters a Crowded Arena

Maryland Makes History: First State to Cap Ozempic Price, Shaking Up Drug Affordability

Maryland Makes History: First State to Cap Ozempic Price, Shaking Up Drug Affordability

Battle Lines Drawn: UK Health Advocates Prepare for Legal Fight Over US Pharma Trade Deal

Battle Lines Drawn: UK Health Advocates Prepare for Legal Fight Over US Pharma Trade Deal

The Hidden Cost of Healing: Unmasking the MRP Maze in Indian Healthcare

The Hidden Cost of Healing: Unmasking the MRP Maze in Indian Healthcare

Remembering Trump's Bold Move: The 100% Tariff Threat on Pharmaceuticals

Remembering Trump's Bold Move: The 100% Tariff Threat on Pharmaceuticals

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

The Dawn of a New Era: Accessible Obesity Treatment for All

The Dawn of a New Era: Accessible Obesity Treatment for All

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

Virginia's Bold Move: A New Era for Prescription Drug Affordability

Virginia's Bold Move: A New Era for Prescription Drug Affordability

The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning

The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning

The Cost of Cures: Unpacking the Price Tag of Novo Nordisk's Breakthrough Drugs in America

The Cost of Cures: Unpacking the Price Tag of Novo Nordisk's Breakthrough Drugs in America

Unpacking Trump's Vision for 340B: A Pilot Program's Complex Ripples

Unpacking Trump's Vision for 340B: A Pilot Program's Complex Ripples

Novo Nordisk: The High-Stakes Balancing Act Between Price and Scale

Novo Nordisk: The High-Stakes Balancing Act Between Price and Scale

Seeing Beyond the Headlines: Why This Investor Stays Bullish on Merck

Seeing Beyond the Headlines: Why This Investor Stays Bullish on Merck

The Pharmaceutical Frontier: Navigating Breakthroughs, Billions, and Bitter Debates

The Pharmaceutical Frontier: Navigating Breakthroughs, Billions, and Bitter Debates

Unveiling the Vision: A Deeper Look at Trump's Ambitious Healthcare Promises

Unveiling the Vision: A Deeper Look at Trump's Ambitious Healthcare Promises

The Great Healthcare Comeback: How Clarity on Pricing and Tariffs Stabilized a Shaken Sector

The Great Healthcare Comeback: How Clarity on Pricing and Tariffs Stabilized a Shaken Sector

Navigating the Future of Wellness: A Human Look at Healthcare's Trajectory Towards 2026

Navigating the Future of Wellness: A Human Look at Healthcare's Trajectory Towards 2026

Looking Back: The Healthcare Conversations That Truly Stuck With Us in 2025

Looking Back: The Healthcare Conversations That Truly Stuck With Us in 2025

Navigating the Complex Currents of Modern Pharmaceuticals

Navigating the Complex Currents of Modern Pharmaceuticals

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

Unlocking Affordable Medicine: A Call for Smarter Biosimilar Regulation

Unlocking Affordable Medicine: A Call for Smarter Biosimilar Regulation

The Great Unbundling: Why Weight Loss Drug Prices Are Finally Coming Down

The Great Unbundling: Why Weight Loss Drug Prices Are Finally Coming Down

Ensuring Everyone Can Afford Medicine: A Call for Policy on Non-Scheduled Drugs

Ensuring Everyone Can Afford Medicine: A Call for Policy on Non-Scheduled Drugs

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

The Fight for Affordable Medicine: Hospitals Take On 340B Program Changes

The Fight for Affordable Medicine: Hospitals Take On 340B Program Changes

Unpacking the Trump Administration's Bold Move to Cut Drug Costs

Unpacking the Trump Administration's Bold Move to Cut Drug Costs

Eli Lilly Slashes Zepbound Prices Amid Political Pressure and Trump's Claims

Eli Lilly Slashes Zepbound Prices Amid Political Pressure and Trump's Claims

Medicare's Big Gamble: Are Pharmacies Truly Ready for Drug Price Negotiations?

Medicare's Big Gamble: Are Pharmacies Truly Ready for Drug Price Negotiations?

The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

Load more